Development of Antibody-Based Cancer Therapeutics

Antibody-based therapeutics represent an important advancement in the progress of cancer treatment options. The discovery and development of therapeutic monoclonal antibodies offers the potential promise of personalized treatment with high specificity and safety. With treatments already available for several cancer types, this class of biologics offers one of the most successful therapeutic strategies for both hematologic cancers and solid tumors in recent years.

In this application note compendium, we look at some of the successful discovery and development methods for monoclonal antibody-based treatments for cancer. These methods take advantage of cutting-edge technologies, such as the iQue Advanced Flow Cytometry Platform from Sartorius, which enables rapid identification and characterization of candidate molecules with superior target reactivity and optimized functionality.

Plus, in this second edition eBook, explore how these systems are also advancing our understanding of emerging viruses and informing therapy development for infectious diseases such as COVID-19.